Monday, October 26, 2026 · Daily editionET --:--:--

Finished

HCC Response Assessment by MRI After SBRT

NCT03088423 · Institut de Cancérologie de Lorraine · Updated 23 March 2017

What is being tested
SBRT delivers high dose selective irradiation with millimeter precision to a small volume. The Cyberknife® is a robotic SBRT dedicated device that can deliver 100 to 200 photobeams to the target
For
Carcinoma, Hepatocellular
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 35 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 Oct 2011, ends 1 Feb 2015. Registered 23 March 2017.
Results
None posted yet.

In the researchers' words

The aim of this work was to describe SBRT different presentations, to study predictive factors for tumor responses following treatment, and to compare tumor response assessments according to the Response Evaluation Criteria
ClinicalTrials.gov, NCT03088423